Adamas Pharmaceuticals, Inc. logo
Adamas Pharmaceuticals, Inc. ADMS

Adamas Pharmaceuticals, Inc. Retained Earnings 2011-2026 | ADMS

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.
Possible uses include
  • reinvestment in development (R&D, equipment, marketing)
  • debt repayment
  • acquisition of other companies
  • creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings Adamas Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-505 M -448 M -343 M -212 M -122 M -62.2 M -10.3 M -20.6 M -71.5 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-10.3 M -505 M -199 M

Retained Earnings of other stocks in the Biotechnology industry

Issuer Retained Earnings Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
-158 M - 2.43 % $ 254 M germanyGermany
ARCA biopharma ARCA biopharma
ABIO
-83.7 M - 1052.0 % $ 415 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-335 M - 5.93 % $ 314 M canadaCanada
Albireo Pharma Albireo Pharma
ALBO
-301 M - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
-351 M - 10.36 % $ 9.8 M usaUSA
I-Mab I-Mab
IMAB
-8.33 B - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.24 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
-405 M - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
-17.1 M - -13.47 % $ 169 M franceFrance
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
-611 M $ 221.14 2.6 % $ 5 B danmarkDanmark
Aptinyx Aptinyx
APTX
-353 M - -39.0 % $ 4.57 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-122 M - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
-108 M - -1.52 % $ 24.7 M usaUSA
Processa Pharmaceuticals Processa Pharmaceuticals
PCSA
-101 M $ 2.37 1.72 % $ 3.1 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
667 M $ 19.6 1.92 % $ 916 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
-308 M - - $ 26.5 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-149 M - - $ 7.46 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
-131 M - -10.17 % $ 12.2 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
-1.19 B - -24.86 % $ 820 K usaUSA
Atreca Atreca
BCEL
-457 M - -11.76 % $ 5.79 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-221 M - 4.01 % $ 150 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
-8.32 B - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
-4.26 B - - $ 546 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
69.4 M - - - russiaRussia
Cara Therapeutics Cara Therapeutics
CARA
-685 M - -3.03 % $ 260 M usaUSA
Phathom Pharmaceuticals Phathom Pharmaceuticals
PHAT
-1.48 B $ 10.35 2.88 % $ 755 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
-1.07 B - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
-141 M - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
-197 M - -9.65 % $ 45.9 M usaUSA
Phio Pharmaceuticals Corp. Phio Pharmaceuticals Corp.
PHIO
-155 M $ 1.27 4.09 % $ 7.6 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
-103 M - -52.27 % $ 4.45 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
-1.1 B $ 1.35 1.89 % $ 344 M britainBritain
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
-555 M $ 8.23 0.61 % $ 110 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
-1.95 B $ 47.4 2.09 % $ 4.26 B schweizSchweiz
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
-439 M - -5.98 % $ 34.1 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
-617 M - - $ 3.74 B usaUSA
Pliant Therapeutics Pliant Therapeutics
PLRX
-859 M $ 1.32 3.13 % $ 81 M usaUSA
PMV Pharmaceuticals PMV Pharmaceuticals
PMVP
-446 M $ 1.39 -0.36 % $ 73 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
-903 M - - $ 2.02 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
-256 M - -4.8 % $ 255 M usaUSA
Enochian Biosciences Enochian Biosciences
ENOB
-510 M - - $ 40.5 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-1.13 B - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
-1.06 B - - $ 867 M germanyGermany
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
-252 M - -74.18 % $ 955 K usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-826 M - - $ 3.67 B usaUSA
Prelude Therapeutics Incorporated Prelude Therapeutics Incorporated
PRLD
-683 M $ 3.26 4.49 % $ 251 M usaUSA
ProQR Therapeutics N.V. ProQR Therapeutics N.V.
PRQR
-258 M $ 1.53 2.35 % $ 99.5 M niderlandNiderland
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
-1.38 B $ 4.51 4.76 % $ 864 M canadaCanada
Homology Medicines Homology Medicines
FIXX
-205 M - 0.77 % $ 53.4 M usaUSA
Akouos Akouos
AKUS
-168 M - 0.23 % $ 488 M usaUSA